PLEC and cancer: In addition, surface-targeting peptides that bind to plectin, such as a peptide derived from Cyclin D2 (Pep5) [40] and a highly CSC-specific hit peptoid (PSC2) [52], exhibit high binding specificity and have been shown to inhibit tumor growth or induce cancer cell death.